Evaluation and management of the patient with pulmonary arterial hypertension
- PMID: 16103472
- DOI: 10.7326/0003-4819-143-4-200508160-00009
Evaluation and management of the patient with pulmonary arterial hypertension
Abstract
Increased pressure in the pulmonary circulation, or pulmonary hypertension, is a common disorder that may complicate various cardiopulmonary conditions, including severe obstructive airways disease and left ventricular dysfunction. An increase in pulmonary arterial pressure that is not due to coexistent cardiopulmonary disease, known as pulmonary arterial hypertension, may occur in the absence of a demonstrable cause (idiopathic or familial); as a complication of systemic conditions, such as connective tissue disease, HIV infection, or chronic liver disease; or as a result of the use of fenfluramine anorexigens, amphetamines, or cocaine. The development of disease-specific therapies for pulmonary arterial hypertension over the past decade underscores the importance of diagnosing pulmonary hypertension early in the course of the condition and implementing a treatment strategy that is based on the condition's cause and severity. In this review, the authors present approaches to the diagnosis and management of pulmonary arterial hypertension, using a hypothetical case to highlight the key management points.
Comment in
-
Thyrotoxicosis as a risk factor for pulmonary arterial hypertension.Ann Intern Med. 2006 Feb 7;144(3):222; author reply 222-3. doi: 10.7326/0003-4819-144-3-200602070-00022. Ann Intern Med. 2006. PMID: 16461975 No abstract available.
Similar articles
-
Prognosis, screening, early detection and differentiation of arterial pulmonary hypertension.Swiss Med Wkly. 2007 Jun 16;137(23-24):331-6. doi: 10.4414/smw.2007.11669. Swiss Med Wkly. 2007. PMID: 17629802 Review.
-
[Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects].G Ital Cardiol (Rome). 2009 May;10(5):271-300. G Ital Cardiol (Rome). 2009. PMID: 19537440 Review. Italian.
-
Current therapeutic approaches to pulmonary arterial hypertension.Rev Esp Cardiol. 2010 Jun;63(6):708-24. doi: 10.1016/s1885-5857(10)70145-6. Rev Esp Cardiol. 2010. PMID: 20515628
-
Drug-associated pulmonary arterial hypertension.Clin Toxicol (Phila). 2018 Sep;56(9):801-809. doi: 10.1080/15563650.2018.1447119. Epub 2018 Mar 6. Clin Toxicol (Phila). 2018. PMID: 29508628
-
[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension].Rev Prat. 2008 Nov 30;58(18):2011-8. Rev Prat. 2008. PMID: 19143272 Review. French.
Cited by
-
Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD.Front Med (Lausanne). 2023 Oct 10;10:1275684. doi: 10.3389/fmed.2023.1275684. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37881627 Free PMC article. Review.
-
New approaches to the treatment of pulmonary hypertension: from bench to bedside.Cardiol Rev. 2010 Mar-Apr;18(2):76-84. doi: 10.1097/CRD.0b013e3181cbcbf3. Cardiol Rev. 2010. PMID: 20160533 Free PMC article. Review.
-
Associated pulmonary arterial hypertension in connective tissue diseases.Maedica (Bucur). 2011 Apr;6(2):141-5. Maedica (Bucur). 2011. PMID: 22205898 Free PMC article.
-
Clinical Effects of Syncope on Disease Severity and Adverse Outcomes in Children with Idiopathic and Heritable Pulmonary Arterial Hypertension.Pediatr Cardiol. 2019 Jan;40(1):209-214. doi: 10.1007/s00246-018-1996-3. Epub 2018 Oct 5. Pediatr Cardiol. 2019. PMID: 30291385
-
Comprehensive Multi-Dimensional MRI for the Simultaneous Assessment of Cardiopulmonary Anatomy and Physiology.Sci Rep. 2017 Jul 13;7(1):5330. doi: 10.1038/s41598-017-04676-8. Sci Rep. 2017. PMID: 28706270 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous